Domain Therapeutics signs a multi-target research collaboration and license agreement with Boehringe...

Domain Therapeutics’ innovative business model gains validation through Prexton Therapeutics acqui...

Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor...